COPD clinical trials in Texas
28 studies for COPD are looking for participants at sites in Texas.
Cities in Texas
- Houston18 studies
- Dallas13 studies
- McKinney7 studies
- El Paso5 studies
- The Woodlands5 studies
- Mesquite4 studies
- Cypress4 studies
- Sugar Land3 studies
- San Antonio3 studies
- Lewisville3 studies
- Denison3 studies
- Brownsville3 studies
- Grand Prairie3 studies
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Humble
- GSK Investigational Site, Huntsville
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Nov 12, 2026 · NCT07780669A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50001, Boerne
- Copd01 50006, McKinney
- Copd01 50005, Tomball
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Nov 6, 2026 · NCT07725939Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
- Victoria Clinical Research Group ( Site 4430), Victoria
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Nov 6, 2026 · NCT07874815A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Premier Pulmonary Critical Care and Sleep, Denison
- Baylor College of Medicine Medical Center, Houston
- Prime Clinical Research - Lewisville, Lewisville
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Nov 5, 2026 · NCT07759245A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
- PanAmerican Clinical Research - Brownville, Brownsville
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07908381To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Horizon Clinical Research Group., Cypress
- Metroplex Pulmonary and Sleep Center, McKinney
- DM Clinical Research - Tomball, Tomball
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Oct 28, 2026 · NCT07684820A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 26, 2026 · NCT07555483A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Boerne
- Research Site, Dallas
- Research Site, Denison
- and 5 more
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Oct 23, 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Solace Clinical Research- Site Number : 8400087, Austin
- IntraCare- Site Number : 8400034, Dallas
- Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
- and 7 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 23, 2026 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, McKinney
- WB Contracted Clinical Research Site, Waxahachie
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 23, 2026 · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Ten20 Clinical Research, Carrollton
- Horizon Clinical Research Group, Cypress
- and 7 more
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Oct 22, 2026 · NCT07363694A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont
RecruitingPhase 4
Ages 40 to 85 · All sexes · Updated Oct 20, 2026 · NCT07053423Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Houston Methodist/Primary Critical Care, Houston
Recruiting
Ages 40 to 84 · All sexes · Updated Oct 19, 2026 · NCT06891755Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Wellness Clinical Research - Allen- Site Number : 8400085, Allen
- REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
- Novel Research - Bellaire- Site Number : 8400116, Bellaire
- and 17 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 19, 2026 · NCT07190209STRIVE Post-Market Registry Study
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
- University of Texas Health Science Center at Houston, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT04302272The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- The Respire Institute, Houston
- Activian Clinical Research, Kingwood
- The Lung & Sleep Institute of North Texas, North Richland Hills
RecruitingObservational study
Ages 40 and older · All sexes · Updated Oct 15, 2026 · NCT07612878A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Boerne
- Research Site, El Paso
- Research Site, Houston
- and 6 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 9, 2026 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, El Paso
- and 5 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 5, 2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Corsicana
- GSK Investigational Site, Dallas
- GSK Investigational Site, Houston
- and 4 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 5, 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Abilene
- Research Site, Brownsville
- Research Site, Dallas
- and 12 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06283966An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- University of Texas Southwestern, Dallas
Recruiting
Ages 40 to 80 · All sexes · Updated Sep 17, 2026 · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Baylor College of Medicine, Houston
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Dallas
- Research Site, Forney
- Research Site, Fort Worth
- and 5 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Dallas
- GSK Investigational Site, DeSoto
- GSK Investigational Site, Greenville
- and 6 more
RecruitingPhase 3
Ages 40 to 75 · All sexes · Updated Jul 28, 2026 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05181826Interprofessional Pharmacogenomics (IPGx) Registry and Repository
- Texas A&M Family Care, Bryan
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 12, 2025 · NCT06726590Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Horizon Clinical Research Group, Houston
- CHRISTUS Trinity Mother Frances Health System, Tyler
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Respire Research Institute, Houston
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.